Capital Fund Management (CFM)’s Merck MRK Stock Holding History

Capital Fund Management (CFM)’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$28.4M	Sell	235,800 -151,800	-39%	-$17.5M	0.13%	204
2025 Q4	$40.8M	Sell	387,600 -469,200	-55%	-$44M	0.11%	237
2025 Q3	$71.9M	Sell	856,800 -216,500	-20%	-$17.8M	0.19%	112
2025 Q2	$85M	Buy	1,073,300 +28,000	+3%	+$2.23M	0.23%	85
2025 Q1	$93.8M	Buy	1,045,300 +423,500	+68%	+$39.5M	0.27%	75
2024 Q4	$61.9M	Buy	621,800 +489,500	+370%	+$50.5M	0.16%	184
2024 Q3	$15M	Sell	132,300 -20,500	-13%	-$2.44M	0.04%	560
2024 Q2	$18.9M	Buy	152,800 +13,800	+10%	+$1.78M	0.06%	430
2024 Q1	$18.3M	Sell	139,000 -39,500	-22%	-$4.87M	0.05%	485
2023 Q4	$19.5M	Sell	178,500 -483,100	-73%	-$50.1M	0.05%	464
2023 Q3	$68.1M	Buy	661,600 +37,800	+6%	+$4.07M	0.24%	100
2023 Q2	$72M	Buy	623,800 +160,300	+35%	+$18.2M	0.29%	71
2023 Q1	$49.3M	Buy	463,500 +240,900	+108%	+$26M	0.24%	104
2022 Q4	$24.7M	Sell	222,600 -304,400	-58%	-$31.1M	0.17%	161
2022 Q3	$45.4M	Buy	527,000 +250,200	+90%	+$22.3M	0.36%	59
2022 Q2	$25.2M	Buy	276,800 +173,100	+167%	+$15.3M	0.23%	101
2022 Q1	$8.51M	Buy	+103,700	New	+$8.18M	0.07%	386
2021 Q1	–	Sell	-30,392	Closed	-$2.37M	–	1496
2020 Q4	$2.37M	Sell	30,392 -41,815	-58%	-$3.2M	0.02%	722
2020 Q3	$5.72M	Buy	+72,207	New	+$5.66M	0.07%	318
2020 Q2	–	Sell	-62,985	Closed	-$4.62M	–	1367
2020 Q1	$4.62M	Sell	62,985 -32,697	-34%	-$2.57M	0.07%	320
2019 Q4	$8.3M	Sell	95,682 -3,459	-3%	-$284K	0.07%	394
2019 Q3	$7.96M	Sell	99,141 -45,064	-31%	-$3.61M	0.07%	344
2019 Q2	$11.5M	Sell	144,205 -612,346	-81%	-$46.9M	0.11%	270
2019 Q1	$60M	Sell	756,551 -713,479	-49%	-$53.4M	0.54%	24
2018 Q4	$107M	Sell	1,470,030 -321,002	-18%	-$22.7M	0.95%	4
2018 Q3	$121M	Buy	1,791,032 +437,016	+32%	+$27.8M	0.66%	7
2018 Q2	$78.4M	Buy	1,354,016 +668,624	+98%	+$37.7M	0.41%	29
2018 Q1	$35.6M	Sell	685,392 -15,825	-2%	-$855K	0.21%	120
2017 Q4	$37.6M	Buy	701,217 +695,767	+12,766%	+$38.6M	0.21%	119
2017 Q3	$333K	Hold	5,450	–	–	﹤0.01%	1295
2017 Q2	$333K	Sell	5,450 -94,005	-95%	-$5.72M	﹤0.01%	1238
2017 Q1	$6.03M	Sell	99,455 -648,922	-87%	-$39.4M	0.05%	405
2016 Q4	$42M	Sell	748,377 -629	-0.1%	-$36.8K	0.36%	62
2016 Q3	$44.6M	Buy	749,006 +713,374	+2,002%	+$41.7M	0.41%	57
2016 Q2	$1.96M	Buy	35,632 +26,829	+305%	+$1.43M	0.02%	737
2016 Q1	$444K	Sell	8,803 -133,411	-94%	-$6.53M	﹤0.01%	1198
2015 Q4	$7.17M	Buy	142,214 +102,076	+254%	+$5.15M	0.07%	351
2015 Q3	$1.89M	Buy	40,138 +31,230	+351%	+$1.66M	0.02%	639
2015 Q2	$484K	Sell	8,908 -7,965	-47%	-$447K	0.01%	1087
2015 Q1	$925K	Sell	16,873 -187,173	-92%	-$10.6M	0.01%	814
2014 Q4	$11.1M	Sell	204,046 -153,427	-43%	-$8.55M	0.13%	207
2014 Q3	$20.2M	Sell	357,473 -309,579	-46%	-$17.4M	0.23%	93
2014 Q2	$36.8M	Buy	667,052 +233,180	+54%	+$12.7M	0.39%	40
2014 Q1	$23.5M	Buy	433,872 +331,797	+325%	+$17.2M	0.29%	63
2013 Q4	$4.88M	Sell	102,075 -100,818	-50%	-$4.61M	0.06%	384
2013 Q3	$9.22M	Sell	202,893 -29,553	-13%	-$1.35M	0.13%	205
2013 Q2	$10.3M	Buy	+232,446	New	+$10.4M	0.16%	146

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Fund Management (CFM)'s MRK Position: Q1 2026 in Review

Capital Fund Management (CFM) sold out of Merck (MRK) in Q1 2026, closing a stake of 47,747 shares — an estimated $5.51M sold.

Capital Fund Management (CFM) first reported a position in MRK in Q3 2013 and held it in 36 quarters. The position peaked at $125M in Q1 2025. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Capital Fund Management (CFM) reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
Capital Fund Management (CFM) sold 47,747 Merck shares in Q1 2026, an estimated $5.51M.
Capital Fund Management (CFM) first reported a position in Merck in Q3 2013 and held it in 36 quarters.
Capital Fund Management (CFM)'s Merck position peaked at $125M in Q1 2025.
3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.